| 2024 |
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2024 |
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease |
Articolo in rivista |
Go to |
| 2024 |
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids |
Articolo in rivista |
Go to |
| 2024 |
The first MASH drug therapy on the horizon: Current perspectives of resmetirom |
Review essay (rassegna critica) |
Go to |
| 2024 |
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD |
Review essay (rassegna critica) |
Go to |
| 2024 |
Food Beliefs and the Risk of Orthorexia in Patients with Inflammatory Bowel Disease |
Articolo in rivista |
Go to |
| 2024 |
Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease? |
Review essay (rassegna critica) |
Go to |
| 2024 |
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies |
Articolo in rivista |
Go to |
| 2024 |
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease |
Articolo in rivista |
Go to |
| 2024 |
Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] |
Nota o commento |
Go to |
| 2024 |
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease |
Articolo in rivista |
Go to |
| 2024 |
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility |
Articolo in rivista |
Go to |
| 2024 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease |
Articolo in rivista |
Go to |
| 2024 |
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria |
Articolo in rivista |
Go to |
| 2024 |
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity |
Articolo in rivista |
Go to |
| 2024 |
Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community |
Articolo in rivista |
Go to |
| 2024 |
Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD |
Articolo in rivista |
Go to |
| 2024 |
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) |
Articolo in rivista |
Go to |
| 2024 |
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis |
Articolo in rivista |
Go to |
| 2024 |
Correction to: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (Nature Medicine, (2023), 29, 10, (2643-2655), 10.1038/s41591-023-02553-8) |
Nota o commento |
Go to |
| 2024 |
Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH |
Articolo in rivista |
Go to |
| 2024 |
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis |
Review essay (rassegna critica) |
Go to |
| 2024 |
Association between metabolic dysfunction-associated steatotic liver disease and risk of urolithiasis: an updated systematic review and meta-analysis |
Articolo in rivista |
Go to |
| 2024 |
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study |
Articolo in rivista |
Go to |
| 2024 |
A global action agenda for turning the tide on fatty liver disease |
Articolo in rivista |
Go to |
| 2024 |
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization |
Articolo in rivista |
Go to |
| 2024 |
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease |
Articolo in rivista |
Go to |
| 2024 |
The PD-1/PD-L1 Axis in the Biology of MASLD |
Review essay (rassegna critica) |
Go to |
| 2023 |
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2023 |
MAFLD: a multisystem disease |
Recensione in rivista |
Go to |
| 2023 |
A global research priority agenda to advance public health responses to fatty liver disease |
Articolo in rivista |
Go to |
| 2023 |
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study |
Articolo in rivista |
Go to |
| 2023 |
Corrigendum to "Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)" [Dig Liver Dis 54 (2022) 170-182] |
Nota o commento |
Go to |
| 2023 |
Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16 |
Nota o commento |
Go to |
| 2023 |
Accuracy, Reliability, and Comprehensiveness of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2023 |
Glycemic control, body weight reduction, or glucose-lowering therapy in diabetic patients: What is better for the liver? |
Recensione in rivista |
Go to |
| 2023 |
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2023 |
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes |
Articolo in rivista |
Go to |
| 2023 |
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis |
Articolo in rivista |
Go to |
| 2023 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2023 |
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2023 |
Measuring the impact of the updated Steatotic liver disease nomenclature and definition |
Nota o commento |
Go to |
| 2023 |
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity |
Articolo in rivista |
Go to |
| 2023 |
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study |
Articolo in rivista |
Go to |
| 2023 |
Individual and population screening of varices needing treatment by a simple, safe and accurate test |
Articolo in rivista |
Go to |
| 2023 |
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study |
Articolo in rivista |
Go to |
| 2023 |
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies |
Articolo in rivista |
Go to |
| 2023 |
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol |
Articolo in rivista |
Go to |
| 2023 |
Acceptance of influenza and Sars-CoV 2 vaccines coadministration in pregnant women according to health action process approach |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2023 |
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis |
Articolo in rivista |
Go to |
| 2023 |
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women |
Articolo in rivista |
Go to |
| 2022 |
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial |
Articolo in rivista |
Go to |
| 2022 |
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD |
Articolo in rivista |
Go to |
| 2022 |
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) |
Articolo in rivista |
Go to |
| 2022 |
PSD3 downregulation confers protection against fatty liver disease |
Articolo in rivista |
Go to |
| 2022 |
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance |
Articolo in rivista |
Go to |
| 2022 |
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) |
Articolo in rivista |
Go to |
| 2022 |
Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2022 |
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis |
Articolo in rivista |
Go to |
| 2022 |
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients |
Articolo in rivista |
Go to |
| 2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2022 |
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2022 |
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation |
Review essay (rassegna critica) |
Go to |
| 2022 |
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
Articolo in rivista |
Go to |
| 2022 |
"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV" |
Articolo in rivista |
Go to |
| 2022 |
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices |
Articolo in rivista |
Go to |
| 2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Go to |
| 2022 |
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2022 |
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment |
Articolo in rivista |
Go to |
| 2022 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? |
Articolo in rivista |
Go to |
| 2022 |
Rare ATG7 genetic variants predispose patients to severe fatty liver disease |
Articolo in rivista |
Go to |
| 2022 |
Global multi-stakeholder endorsement of the MAFLD definition |
Lettera |
Go to |
| 2022 |
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators |
Articolo in rivista |
Go to |
| 2022 |
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" |
Lettera |
Go to |
| 2022 |
NAFLD/NASH |
Nota o commento |
Go to |
| 2022 |
Geographical similarity and differences in the burden and genetic predisposition of NAFLD |
Review essay (rassegna critica) |
Go to |
| 2022 |
Advancing the global public health agenda for NAFLD: a consensus statement |
Articolo in rivista |
Go to |
| 2021 |
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease |
Articolo in rivista |
Go to |
| 2021 |
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD |
Capitolo o Saggio |
Go to |
| 2021 |
Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography |
Articolo in rivista |
Go to |
| 2021 |
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population |
Articolo in rivista |
Go to |
| 2021 |
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort |
Articolo in rivista |
Go to |
| 2021 |
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey |
Articolo in rivista |
Go to |
| 2021 |
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study |
Articolo in rivista |
Go to |
| 2021 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis |
Articolo in rivista |
Go to |
| 2021 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2021 |
Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN) |
Articolo in rivista |
Go to |
| 2021 |
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores |
Articolo in rivista |
Go to |
| 2021 |
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update |
Articolo in rivista |
Go to |
| 2021 |
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) |
Articolo in rivista |
Go to |
| 2021 |
Is there an ‘ideal’ diet for patients with NAFLD? |
Articolo in rivista |
Go to |
| 2021 |
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes |
Articolo in rivista |
Go to |
| 2021 |
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus |
Articolo in rivista |
Go to |
| 2021 |
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
Articolo in rivista |
Go to |
| 2021 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis |
Articolo in rivista |
Go to |
| 2021 |
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2021 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis |
Articolo in rivista |
Go to |
| 2021 |
Italian association for the study of the liver position statement on SARS-CoV2 vaccination |
Articolo in rivista |
Go to |
| 2021 |
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2 |
Articolo in rivista |
Go to |
| 2021 |
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort |
Articolo in rivista |
Go to |
| 2021 |
Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment |
Articolo in rivista |
Go to |
| 2021 |
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials |
Articolo in rivista |
Go to |
| 2021 |
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage |
Articolo in rivista |
Go to |
| 2020 |
The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis |
Articolo in rivista |
Go to |
| 2020 |
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2020 |
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation |
Articolo in rivista |
Go to |
| 2020 |
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study |
Articolo in rivista |
Go to |
| 2020 |
Optimization of hepatitis C virus screening strategies by birth cohort in Italy |
Articolo in rivista |
Go to |
| 2020 |
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2020 |
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis |
Articolo in rivista |
Go to |
| 2020 |
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: How to manage in clinical practice |
Review essay (rassegna critica) |
Go to |
| 2020 |
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD |
Articolo in rivista |
Go to |
| 2020 |
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study |
Articolo in rivista |
Go to |
| 2020 |
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) |
Articolo in rivista |
Go to |
| 2020 |
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2020 |
Genetic variants in the MTHFR are not associated with fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2020 |
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement |
Review essay (rassegna critica) |
Go to |
| 2020 |
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver |
Articolo in rivista |
Go to |
| 2020 |
Outcomes of Liver Transplant for Adults With Wilson’s Disease |
Articolo in rivista |
Go to |
| 2020 |
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy |
Articolo in rivista |
Go to |
| 2020 |
MAFLD vs NAFLD: Let the contest begin! |
Nota o commento |
Go to |
| 2020 |
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ |
Articolo in rivista |
Go to |
| 2020 |
Machine Perfusions in Liver Transplantation: The Evidence-Based Position Paper of the Italian Society of Organ and Tissue Transplantation |
Articolo in rivista |
Go to |
| 2020 |
Prevalence, predictors, and severity of lean nonalcoholic fatty liver disease in patients living with human immunodeficiency virus |
Articolo in rivista |
Go to |
| 2020 |
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update |
Review essay (rassegna critica) |
Go to |
| 2020 |
Identification of patients with advanced fibrosis due to nonalcoholic fatty liver disease: Considerations for best practice |
Review essay (rassegna critica) |
Go to |
| 2020 |
Extrahepatic Manifestations of Chronic Viral C Hepatitis |
Review essay (rassegna critica) |
Go to |
| 2020 |
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD |
Articolo in rivista |
Go to |
| 2020 |
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2020 |
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis |
Articolo in rivista |
Go to |
| 2020 |
Biochemical biomarkers of NAFLD/NASH |
Capitolo o Saggio |
Go to |
| 2020 |
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients |
Articolo in rivista |
Go to |
| 2019 |
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data |
Articolo in rivista |
Go to |
| 2019 |
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2019 |
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis |
Articolo in rivista |
Go to |
| 2019 |
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation |
Articolo in rivista |
Go to |
| 2019 |
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2019 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2019 |
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals |
Articolo in rivista |
Go to |
| 2019 |
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2019 |
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives |
Articolo in rivista |
Go to |
| 2019 |
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy |
Articolo in rivista |
Go to |
| 2019 |
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience |
Articolo in rivista |
Go to |
| 2019 |
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients |
Articolo in rivista |
Go to |
| 2019 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial |
Articolo in rivista |
Go to |
| 2019 |
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity |
Articolo in rivista |
Go to |
| 2019 |
Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2019 |
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease |
Articolo in rivista |
Go to |
| 2019 |
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2019 |
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives |
Articolo in rivista |
Go to |
| 2019 |
Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis |
Articolo in rivista |
Go to |
| 2019 |
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) |
Articolo in rivista |
Go to |
| 2019 |
AISF position paper on HCV in immunocompromised patients |
Articolo in rivista |
Go to |
| 2019 |
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) |
Articolo in rivista |
Go to |
| 2019 |
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Articolo in rivista |
Go to |
| 2019 |
Current epidemiology of HCV in Sicily: the RESIST-HCV model |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2019 |
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2018 |
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals |
Articolo in rivista |
Go to |
| 2018 |
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver |
Articolo in rivista |
Go to |
| 2018 |
Is global elimination of HCV realistic? |
Articolo in rivista |
Go to |
| 2018 |
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. |
Articolo in rivista |
Go to |
| 2018 |
L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS |
Proceedings |
Go to |
| 2018 |
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study |
Articolo in rivista |
Go to |
| 2018 |
Liver and statins: a critical appraisal of the evidence |
Articolo in rivista |
Go to |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Go to |
| 2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Go to |
| 2018 |
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population |
Articolo in rivista |
Go to |
| 2018 |
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B |
Articolo in rivista |
Go to |
| 2018 |
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis |
Articolo in rivista |
Go to |
| 2018 |
Expert opinion on managing chronic HCV in patients with cardiovascular disease |
Articolo in rivista |
Go to |
| 2018 |
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers |
Articolo in rivista |
Go to |
| 2018 |
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) |
Articolo in rivista |
Go to |
| 2018 |
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis |
Articolo in rivista |
Go to |
| 2018 |
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2018 |
Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? |
Articolo in rivista |
Go to |
| 2018 |
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 |
Articolo in rivista |
Go to |
| 2018 |
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2018 |
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort |
Poster pubblicato in rivista |
Go to |
| 2018 |
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) |
Nota o commento |
Go to |
| 2018 |
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) |
Articolo in rivista |
Go to |
| 2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Go to |
| 2017 |
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2017 |
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV |
Articolo in rivista |
Go to |
| 2017 |
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis |
Articolo in rivista |
Go to |
| 2017 |
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study |
Articolo in rivista |
Go to |
| 2017 |
Hepatitis C virus and cardiovascular: A review |
Articolo in rivista |
Go to |
| 2017 |
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter |
Articolo in rivista |
Go to |
| 2017 |
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS |
Articolo in rivista |
Go to |
| 2017 |
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values |
Articolo in rivista |
Go to |
| 2017 |
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel |
Articolo in rivista |
Go to |
| 2017 |
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2017 |
Coffee and tea breaks for liver health |
Articolo in rivista |
Go to |
| 2017 |
Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study |
Articolo in rivista |
Go to |
| 2017 |
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD |
Articolo in rivista |
Go to |
| 2017 |
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma |
Articolo in rivista |
Go to |
| 2017 |
Can we prevent and modify cardiometabolic disorders by controlling HCV infection? |
Articolo in rivista |
Go to |
| 2017 |
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2017 |
Evidence-Based Medicine and the Problem of Healthy Volunteers |
Articolo in rivista |
Go to |
| 2017 |
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2017 |
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity |
Articolo in rivista |
Go to |
| 2017 |
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B |
Articolo in rivista |
Go to |
| 2017 |
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study |
Articolo in rivista |
Go to |
| 2017 |
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network |
Articolo in rivista |
Go to |
| 2017 |
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma |
Articolo in rivista |
Go to |
| 2017 |
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study |
Articolo in rivista |
Go to |
| 2017 |
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions |
Articolo in rivista |
Go to |
| 2017 |
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies |
Articolo in rivista |
Go to |
| 2017 |
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon |
Articolo in rivista |
Go to |
| 2017 |
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals |
Articolo in rivista |
Go to |
| 2017 |
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study |
Articolo in rivista |
Go to |
| 2017 |
Reply |
Lettera |
Go to |
| 2017 |
Emerging Increase in the prevalence and severity of nonalcoholic fatty liver disease: epidemiological study from general Mediterranean population |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2016 |
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies |
Articolo in rivista |
Go to |
| 2016 |
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent |
Articolo in rivista |
Go to |
| 2016 |
Diet, Weight Loss, and Liver Health in NAFLD: Pathophysiology, Evidence and Practice |
Review essay (rassegna critica) |
Go to |
| 2016 |
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2016 |
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model |
Articolo in rivista |
Go to |
| 2016 |
The cheating liver: imaging of focal steatosis and fatty sparing |
Articolo in rivista |
Go to |
| 2016 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2016 |
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels |
Articolo in rivista |
Go to |
| 2016 |
From current status to optimization of HCV treatment: Recommendations from an expert panel |
Articolo in rivista |
Go to |
| 2016 |
Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2016 |
Pathophysiology of non alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2016 |
IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection |
Articolo in rivista |
Go to |
| 2016 |
Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature |
Articolo in rivista |
Go to |
| 2016 |
Reply |
Lettera |
Go to |
| 2016 |
Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis' |
Lettera |
Go to |
| 2016 |
Reply |
Lettera |
Go to |
| 2016 |
A "systems medicine" approach to the study of non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2015 |
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis |
Articolo in rivista |
Go to |
| 2015 |
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity |
Abstract in rivista |
Go to |
| 2015 |
Current and future HCV therapy: Do we still need other anti-HCV drugs? |
Articolo in rivista |
Go to |
| 2015 |
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2015 |
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis |
Articolo in rivista |
Go to |
| 2015 |
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
Articolo in rivista |
Go to |
| 2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C |
Articolo in rivista |
Go to |
| 2015 |
Genetic background in nonalcoholic fatty liver disease: A comprehensive review |
Articolo in rivista |
Go to |
| 2015 |
The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. |
Articolo in rivista |
Go to |
| 2015 |
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis |
Articolo in rivista |
Go to |
| 2015 |
Sorafenib for hepatocellular carcinoma: From randomized controlled trials to clinical practice |
Articolo in rivista |
Go to |
| 2015 |
Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. |
Articolo in rivista |
Go to |
| 2015 |
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2015 |
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2015 |
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage |
Articolo in rivista |
Go to |
| 2015 |
Reply |
Lettera |
Go to |
| 2015 |
Reply |
Lettera |
Go to |
| 2015 |
Response to Dr. Sertoglu and colleagues |
Lettera |
Go to |
| 2015 |
Epicardial fat in patients with non-alcoholic fatty liver disease |
Lettera |
Go to |
| 2015 |
Statin use and non-alcoholic steatohepatitis in at risk individuals |
Articolo in rivista |
Go to |
| 2015 |
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease |
Articolo in rivista |
Go to |
| 2014 |
Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” |
Recensione in rivista |
Go to |
| 2014 |
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2014 |
Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF) |
Articolo in rivista |
Go to |
| 2014 |
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2014 |
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2014 |
Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern? |
Recensione in rivista |
Go to |
| 2014 |
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women |
Abstract in rivista |
Go to |
| 2014 |
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2013 |
Cardiovascular diseases and HCV infection: a simple association or more? |
Articolo in rivista |
Go to |
| 2013 |
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Go to |
| 2013 |
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. |
Articolo in rivista |
Go to |
| 2013 |
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2013 |
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2013 |
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients". |
Articolo in rivista |
Go to |
| 2013 |
Metabolic Factors and Chronic Hepatitis C: A Complex Interplay |
Articolo in rivista |
Go to |
| 2013 |
Chemoprevention for hepatocellular carcinoma: the role of statins |
Articolo in rivista |
Go to |
| 2013 |
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Proceedings |
Go to |
| 2013 |
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Go to |
| 2013 |
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection |
Articolo in rivista |
Go to |
| 2013 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Go to |
| 2013 |
Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2013 |
Update on treatment strategies in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2013 |
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. |
Articolo in rivista |
Go to |
| 2013 |
Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2013 |
Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? |
Articolo in rivista |
Go to |
| 2013 |
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance |
Articolo in rivista |
Go to |
| 2013 |
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2013 |
How to optimize HCV therapy in genotype 1 patients: predictors of response. |
Articolo in rivista |
Go to |
| 2013 |
Reply. |
Articolo in rivista |
Go to |
| 2012 |
Hyperuricaemia:
another metabolic feature affecting the severity of chronic hepatitis because of
HCV infection. |
Articolo in rivista |
Go to |
| 2012 |
Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. |
Articolo in rivista |
Go to |
| 2012 |
Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. |
Articolo in rivista |
Go to |
| 2012 |
Reproductive status is associated with the severity of fibrosis in women with hepatitis C |
Articolo in rivista |
Go to |
| 2012 |
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. |
Articolo in rivista |
Go to |
| 2012 |
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with
Genotype 1 Chronic Hepatitis C |
Articolo in rivista |
Go to |
| 2012 |
Iperuricemia: significato clinico e nuove prospettive di trattamento |
Proceedings |
Go to |
| 2012 |
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in
patients with chronic liver diseases. |
Articolo in rivista |
Go to |
| 2012 |
Chronic hepatitis C and atherosclerosis: A complex pathogenic puzzle. |
Articolo in rivista |
Go to |
| 2012 |
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. |
Articolo in rivista |
Go to |
| 2012 |
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. |
Articolo in rivista |
Go to |
| 2012 |
Assessment by Fibroscan of fibrosis in nonalcoholic fatty
liver disease: XL versus M probe? |
Articolo in rivista |
Go to |
| 2012 |
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Go to |
| 2012 |
Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? |
Articolo in rivista |
Go to |
| 2012 |
Methylenetetrahydrofolate reductase homozygosis
and low-density lipoproteins in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2012 |
Enoxaparin Prevents Portal Vein Thrombosis
and Liver Decompensation in Patients With Advanced Cirrhosis. |
Articolo in rivista |
Go to |
| 2012 |
herapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to
treat? |
Articolo in rivista |
Go to |
| 2011 |
LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY
ACIDS |
Proceedings |
Go to |
| 2011 |
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Go to |
| 2011 |
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. |
Articolo in rivista |
Go to |
| 2011 |
Hyperuricemia in non-alcoholic fatty liver disease: authors' reply. |
Articolo in rivista |
Go to |
| 2011 |
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. |
Articolo in rivista |
Go to |
| 2011 |
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis |
Articolo in rivista |
Go to |
| 2011 |
Optimal therapy in hepatitis C virus genotypes 2 and 3 patients. |
Articolo in rivista |
Go to |
| 2011 |
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. |
Articolo in rivista |
Go to |
| 2011 |
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. |
Articolo in rivista |
Go to |
| 2011 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Go to |
| 2011 |
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. |
Articolo in rivista |
Go to |
| 2011 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Go to |
| 2011 |
Liver follicular helper T-cells in chronic hepatitis C |
Abstract in rivista |
Go to |
| 2011 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Go to |
| 2011 |
Is liver stiffness measurement unreliable in obese patients? authors' reply. |
Articolo in rivista |
Go to |
| 2010 |
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. |
Articolo in rivista |
Go to |
| 2010 |
HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B |
Proceedings |
Go to |
| 2010 |
Replay |
Articolo in rivista |
Go to |
| 2010 |
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT |
Abstract in rivista |
Go to |
| 2010 |
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C |
Articolo in rivista |
Go to |
| 2010 |
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Go to |
| 2010 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Go to |
| 2010 |
Reply |
Articolo in rivista |
Go to |
| 2009 |
Reply |
Articolo in rivista |
Go to |
| 2009 |
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus
cirrhosis. |
Articolo in rivista |
Go to |
| 2009 |
HEPATITIS C AND DIABETES: THE INEVITABLE COINCIDENCE? |
Articolo in rivista |
Go to |
| 2009 |
Non-alcoholic fatty liver disease pathogenesis: The present and the future |
Articolo in rivista |
Go to |
| 2009 |
Insulin resistance in HCV mono-infected and in HIV/HCV
co-infected patients: Looking to the future. |
Articolo in rivista |
Go to |
| 2009 |
Reply |
Articolo in rivista |
Go to |
| 2009 |
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis |
Articolo in rivista |
Go to |
| 2009 |
Time course of insulin resistance during antiviral
therapy in non-diabetic, non-cirrhotic patients with
genotype 1 HCV infection |
Articolo in rivista |
Go to |
| 2009 |
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection |
Articolo in rivista |
Go to |
| 2008 |
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome |
Proceedings |
Go to |
| 2008 |
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. |
Articolo in rivista |
Go to |
| 2008 |
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS |
Articolo in rivista |
Go to |
| 2008 |
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. |
Articolo in rivista |
Go to |
| 2008 |
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis |
Articolo in rivista |
Go to |
| 2008 |
Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease |
Proceedings |
Go to |
| 2008 |
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease |
Proceedings |
Go to |
| 2008 |
Reply |
Articolo in rivista |
Go to |
| 2008 |
Insulin resistance and diabetes increase fibrosis in the liver of patients with
genotype 1 HCV infection. |
Articolo in rivista |
Go to |
| 2008 |
Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica |
Proceedings |
Go to |
| 2007 |
INSULIN RESISTANCE AND SEVERITY OF
FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. |
Proceedings |
Go to |
| 2007 |
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Go to |
| 2007 |
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier |
Proceedings |
Go to |
| 2007 |
STORIA NATURALE DELLA CIRROSI EPATICA |
Capitolo o Saggio |
Go to |
| 2005 |
Il carcinoma dell'esofago |
Articolo in rivista |
Go to |
